| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |




From GERMEN,*
INSERM EMI-0011,
and INSERM U492,
Université Paris XII
Val-De-Marne, Créteil, France
The urokinase-type plasminogen activator (uPA) system is a dynamic complex in which the membrane receptor uPAR binds uPA that binds the plasminogen activator inhibitor (PAI)-1 localized in the extracellular matrix, resulting in endocytosis of the whole complex by the low-density lipoprotein receptor-related protein (LRP). High expression of PAI-1 is paradoxically associated with marked tumor spreading and poor prognosis. We previously reported a nonproteolytic role of the [uPAR:uPA:PAI-1:LRP] complex operative in cell migration. Here we explored whether matrix PAI-1 could be used as a migration support by human breast cancer cells. We showed that the uPA system and LRP are localized at filopodia of invasive cells, and that formation/internalization of the [uPAR:uPA:PAI-1:LRP] complex is required for attachment and migration of cancer cells on plastic and on a PAI-1 coat. PAI-1 increased both filopodia formation and migration of cancer cells suggesting a chemokine-like activity. Migration velocity, expression of the uPA system, use of the [uPAR:uPA:PAI-1:LRP] complex to migrate, and promigratory effects of PAI-1 paralleled cancer cell invasiveness. Phenotyping and functional analysis of invasive cancer cell subclones indicated that different cell subpopulations may use different strategies to migrate depending on both the environment and their expression of the uPA system, some of them taking advantage of abundant available PAI-1.
This article has been cited by other articles:
![]() |
A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies Physiol Rev, July 1, 2008; 88(3): 887 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dedieu, B. Langlois, J. Devy, B. Sid, P. Henriet, H. Sartelet, G. Bellon, H. Emonard, and L. Martiny LRP-1 Silencing Prevents Malignant Cell Invasion despite Increased Pericellular Proteolytic Activities Mol. Cell. Biol., May 1, 2008; 28(9): 2980 - 2995. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Maquerlot, S. Galiacy, M. Malo, C. Guignabert, D. A. Lawrence, M.-P. d'Ortho, and G. Barlovatz-Meimon Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing Am. J. Pathol., November 1, 2006; 169(5): 1624 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. De Taeye, T. Novitskaya, L. Gleaves, J. W. Covington, and D. E. Vaughan Bone Marrow Plasminogen Activator Inhibitor-1 Influences the Development of Obesity J. Biol. Chem., October 27, 2006; 281(43): 32796 - 32805. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lafuste, C. Sonnet, B. Chazaud, P. A. Dreyfus, R. K. Gherardi, U. M. Wewer, and F.-J. Authier ADAM12 and {alpha}9{beta}1 Integrin Are Instrumental in Human Myogenic Cell Differentiation Mol. Biol. Cell, February 1, 2005; 16(2): 861 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sato, T. Tanaka, K. Maemura, T. Uchiyama, H. Sato, T. Maeno, T. Suga, T. Iso, Y. Ohyama, M. Arai, et al. The PAI-1 Gene as a Direct Target of Endothelial PAS Domain Protein-1 in Adenocarcinoma A549 Cells Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 209 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chazaud, C. Sonnet, P. Lafuste, G. Bassez, A.-C. Rimaniol, F. Poron, F.-J. Authier, P. A. Dreyfus, and R. K. Gherardi Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth J. Cell Biol., December 8, 2003; 163(5): 1133 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Orr, C. A. Elzie, D. F. Kucik, and J. E. Murphy-Ullrich Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration J. Cell Sci., July 15, 2003; 116(14): 2917 - 2927. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stefansson and D. A. Lawrence Old Dogs and New Tricks, Proteases, Inhibitors, and Cell Migration Sci. Signal., July 1, 2003; 2003(189): pe24 - pe24. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. M. Knisely, W. Lu, L. M. McCormick, J. Wang, J. Henkin, A. L. Schwartz, and G. Bu Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell Migration J. Biol. Chem., October 25, 2002; 277(44): 42366 - 42371. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Palmieri, J. W. Lee, R. L. Juliano, and F. C. Church Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer Cells J. Biol. Chem., October 18, 2002; 277(43): 40950 - 40957. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Vaughan PAI-1 and Cellular Migration: Dabbling in Paradox Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1522 - 1523. [Full Text] [PDF] |
||||
![]() |
K. M. Providence, L. A. White, J. Tang, J. Gonclaves, L. Staiano-Coico, and P. J. Higgins Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene J. Cell Sci., January 10, 2002; 115(19): 3767 - 3777. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |